Jazz Pharmaceuticals
Jazz Pharmaceuticals is a specialty pharmaceutical company that identifies develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. Jazz Pharmaceuticals focuses on identifying, developing, and commercializing products for neurology and psychiatry primarily in the United States. Its products include Xyrem for the treatment of cataplexy and excessive daytime sleepiness in patients with narcolepsy; Cystadane for the treatment of homocystinuria, an inherited metabolic disease; and Antizol to treat ethylene glycol and methanol poisoning. Its late-stage product candidates comprise Luvox CR, an extended-release formulation of fluvoxamine, a selective serotonin reuptake inhibitor, which is used for the treatment of obsessive-compulsive disorder and social anxiety disorder; and JZP-6, a liquid dosage form of sodium oxybate in Xyrem, for the treatment of fibromyalgia syndrome.
Domain
jazzpharma.com
Country
United StatesIndustry
BiotechnologyEmployees
1001-5000
Last Funding
$850.0M
Founded
2002
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does Jazz Pharmaceuticals use?+
Jazz Pharmaceuticals uses 15 technologies including Drupal, Drupal Multisite, Font Awesome.
What industry is Jazz Pharmaceuticals in?+
Jazz Pharmaceuticals operates in the Biotechnology industry.
Where is Jazz Pharmaceuticals based?+
Jazz Pharmaceuticals is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026